Holen Sie sich die Stockscreener-App
3.68
1.94%
0.07
Handel nachbörslich:
3.68
Schlusskurs vom Vortag:
$3.61
Offen:
$3.62
24-Stunden-Volumen:
16,222
Relative Volume:
0.29
Marktkapitalisierung:
$7.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.37M
KGV:
-4.0444
EPS:
-0.9099
Netto-Cashflow:
$-7.34M
1W Leistung:
+12.20%
1M Leistung:
-13.41%
6M Leistung:
-85.96%
1J Leistung:
-77.30%
1-Tages-Spanne:
$3.5409
$3.73
1-Wochen-Bereich:
$3.22
$3.81
52-Wochen-Spanne:
$3.22
$53.10
Cardio Diagnostics Holdings Inc Stock (CDIO) Company Profile
Firmenname
Cardio Diagnostics Holdings Inc
Sektor
Branche
Telefon
855-226-9991
Adresse
311 W. SUPERIOR STREET, CHICAGO
Vergleichen Sie CDIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDIO
Cardio Diagnostics Holdings Inc
|
3.68 | 7.88M | 0 | -9.37M | -7.34M | -0.9099 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Cardio Diagnostics Holdings Inc Aktie (CDIO) Neueste Nachrichten
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Up 53.1% in May - Defense World
Cardio Diagnostics secures Japan patent for heart disease biomarkers By Investing.com - Investing.com South Africa
Cardio Diagnostics secures Japanese patent for AI-driven cardiovascular disease detection technology - BioSpectrum Asia
Cardio Diagnostics Holdings Secures Japanese Patent For AI Cardiovascular Detection Technology - MarketScreener
Cardio Diagnostics (CDIO) Secures New Patent for Biomarkers in J - GuruFocus
Cardio Diagnostics (CDIO) Secures New Patent for Biomarkers in Japan | CDIO Stock News - GuruFocus
Cardio Diagnostics secures Japan patent for heart disease biomarkers - Investing.com
Cardio Diagnostics secures Japanese patent for set of biomarkers - TipRanks
Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology - Business Wire
Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory - Insider Monkey
Cardio Diagnostics regains Nasdaq compliance following reverse stock split - MSN
Cardio Diagnostics (CDIO) Regains Nasdaq Compliance After Revers - GuruFocus
Cardio Diagnostics Regains Nasdaq Compliance After Reverse Stock Split - Nasdaq
Cardio Diagnostics (CDIO) Regains Nasdaq Compliance After Reverse Stock Split | CDIO Stock News - GuruFocus
Cardio Diagnostics regains compliance with Nasdaq - TipRanks
Cardio Diagnostics Holdings Regains Compliance With Nasdaq Minimum Bid Price - marketscreener.com
Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price - Business Wire
Cardio Diagnostics Regains Nasdaq Compliance by May 2025 - TipRanks
Cardio Diagnostics Brings AI-Powered Heart Disease Tests to Puerto Rico in Major US Expansion - Stock Titan
Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico - Eagle-Tribune
Cardio Diagnostics drops on 1-for-30 reverse stock split - MSN
Cardio Diagnostics Holdings First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cardio Diagnostics (CDIO) Trading Resumes After Temporary Halt | - GuruFocus
Cardio Diagnostics (CDIO) Trading Resumes After Temporary Halt | CDIO Stock News - GuruFocus
CDIO Trading Halted Due to Volatility Pause | CDIO Stock News - GuruFocus
Cardio Diagnostics Announces Reverse Stock Split - TipRanks
Cardio Diagnostics (CDIO) Projected to Post Earnings on Wednesday - The AM Reporter
Trading Halt for Cardio Diagnostics (CDIO) Sparks Anticipation | - GuruFocus
Trading Halt for Cardio Diagnostics (CDIO) Sparks Anticipation | CDIO Stock News - GuruFocus
Cardio Diagnostics Holdings Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Cardio Diagnostics (CDIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Cardio Diagnostics files to sell 1.23M shares of common stocks by selling shareholders - MSN
Cardio Diagnostics enacts 1-for-30 reverse stock split By Investing.com - Investing.com India
Cardio Diagnostics announces 1-for-30 reverse stock split - MSN
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split - BioSpace
Cardio Diagnostics enacts 1-for-30 reverse stock split - Investing.com
Geode Capital Management LLC Acquires 179,978 Shares of Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) - Defense World
Cardio Diagnostics Holdings Inc [CDIO] stock for 9,763 USD was acquired by Philibert Robert - knoxdaily.com
Metric Analysis: Cardio Diagnostics Holdings Inc (CDIO)’s Key Ratios in the Limelight - DWinneX
Cardio Diagnostics Holdings Inc (CDIO) can make a big difference with a little luck - Sete News
Cardio Diagnostics Holdings Inc [CDIO] Insider Activity: An Update for Investors - knoxdaily.com
Cardio Diagnostics Holdings Inc (CDIO Stock: A Sea of Opportunity - investchronicle.com
Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Decreases By 58.1% - Defense World
Nothing is Better Than Cardio Diagnostics Holdings Inc (CDIO) stock at the moment - Sete News
Cardio Diagnostics Holdings Inc [CDIO] Shares Fall Approximately -47.44% Over the Year - knoxdaily.com
Finanzdaten der Cardio Diagnostics Holdings Inc-Aktie (CDIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cardio Diagnostics Holdings Inc-Aktie (CDIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dogan Meeshanthini | Chief Technology Officer |
Sep 06 '24 |
Buy |
0.29 |
68,965 |
20,000 |
197,310 |
| Dogan Meeshanthini | Chief Executive Officer |
Sep 06 '24 |
Buy |
0.29 |
68,965 |
20,000 |
1,683,867 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):